ID   NEK3_HUMAN              Reviewed;         506 AA.
AC   P51956; A8K2J4; Q5TAP2; Q8J023; Q8WUN5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   15-MAR-2017, entry version 172.
DE   RecName: Full=Serine/threonine-protein kinase Nek3;
DE            EC=2.7.11.1;
DE   AltName: Full=HSPK 36;
DE   AltName: Full=Never in mitosis A-related kinase 3;
DE            Short=NimA-related protein kinase 3;
GN   Name=NEK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=12063396;
RA   Kimura M., Okano Y.;
RT   "Molecular cloning and characterization of the human NIMA-related
RT   protein kinase 3 gene (NEK3).";
RL   Cytogenet. Cell Genet. 95:177-182(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 48-506 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=7522034;
RA   Schultz S.J., Fry A.M., Suetterlin C., Ried T., Nigg E.A.;
RT   "Cell cycle-dependent expression of Nek2, a novel human protein kinase
RT   related to the NIMA mitotic regulator of Aspergillus nidulans.";
RL   Cell Growth Differ. 5:625-635(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 76-189.
RX   PubMed=8274451;
RA   Schultz S.J., Nigg E.A.;
RT   "Identification of 21 novel human protein kinases, including 3 members
RT   of a family related to the cell cycle regulator nimA of Aspergillus
RT   nidulans.";
RL   Cell Growth Differ. 4:821-830(1993).
RN   [8]
RP   FUNCTION, INTERACTION WITH PRLR; VAV1 AND VAV2, AND ENZYME REGULATION.
RX   PubMed=15618286; DOI=10.1210/me.2004-0443;
RA   Miller S.L., DeMaria J.E., Freier D.O., Riegel A.M., Clevenger C.V.;
RT   "Novel association of Vav2 and Nek3 modulates signaling through the
RT   human prolactin receptor.";
RL   Mol. Endocrinol. 19:939-949(2005).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, AND INTERACTION WITH PXN.
RX   PubMed=17297458; DOI=10.1038/sj.onc.1210264;
RA   Miller S.L., Antico G., Raghunath P.N., Tomaszewski J.E.,
RA   Clevenger C.V.;
RT   "Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization
RT   and motility of breast cancer cells.";
RL   Oncogene 26:4668-4678(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-479, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-23; ARG-60; HIS-122; LEU-170;
RP   GLY-259; ASP-305; ASN-461 AND LYS-477.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase which influences neuronal morphogenesis
CC       and polarity through effects on microtubules. Regulates
CC       microtubule acetylation in neurons. Contributes to prolactin-
CC       mediated phosphorylation of PXN and VAV2. Implicated in prolactin-
CC       mediated cytoskeletal reorganization and motility of breast cancer
CC       cells through mechanisms involving RAC1 activation and
CC       phosphorylation of PXN and VAV2. {ECO:0000269|PubMed:15618286,
CC       ECO:0000269|PubMed:17297458}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Prolactin stimulates its activity.
CC       {ECO:0000269|PubMed:15618286}.
CC   -!- SUBUNIT: Interacts with PXN, PRLR, VAV1 and VAV2 and this
CC       interaction is prolactin-dependent. {ECO:0000269|PubMed:15618286,
CC       ECO:0000269|PubMed:17297458}.
CC   -!- INTERACTION:
CC       P52735:VAV2; NbExp=3; IntAct=EBI-476041, EBI-297549;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell projection,
CC       axon {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51956-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51956-2; Sequence=VSP_035427;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Up-regulated in malignant versus normal breast
CC       tissue. Isoform 2 shows a high level of expression in testis,
CC       ovary and brain. {ECO:0000269|PubMed:12063396,
CC       ECO:0000269|PubMed:17297458}.
CC   -!- PTM: Phosphorylation at Thr-479 regulates its catalytic activity.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI12895.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=EAX08907.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB072828; BAC15599.1; -; mRNA.
DR   EMBL; AK290259; BAF82948.1; -; mRNA.
DR   EMBL; AL139082; CAI12895.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471075; EAX08907.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC019916; AAH19916.2; -; mRNA.
DR   EMBL; Z29067; CAA82310.1; -; mRNA.
DR   EMBL; Z25434; CAA80921.1; -; mRNA.
DR   CCDS; CCDS73576.1; -. [P51956-1]
DR   PIR; I38224; I38224.
DR   RefSeq; NP_001139571.1; NM_001146099.1. [P51956-2]
DR   RefSeq; NP_002489.1; NM_002498.2. [P51956-1]
DR   RefSeq; NP_689933.1; NM_152720.2. [P51956-1]
DR   UniGene; Hs.409989; -.
DR   ProteinModelPortal; P51956; -.
DR   SMR; P51956; -.
DR   BioGrid; 110827; 8.
DR   IntAct; P51956; 5.
DR   STRING; 9606.ENSP00000383210; -.
DR   BindingDB; P51956; -.
DR   ChEMBL; CHEMBL5679; -.
DR   GuidetoPHARMACOLOGY; 2118; -.
DR   iPTMnet; P51956; -.
DR   PhosphoSitePlus; P51956; -.
DR   BioMuta; NEK3; -.
DR   DMDM; 20178297; -.
DR   EPD; P51956; -.
DR   MaxQB; P51956; -.
DR   PaxDb; P51956; -.
DR   PeptideAtlas; P51956; -.
DR   PRIDE; P51956; -.
DR   DNASU; 4752; -.
DR   Ensembl; ENST00000610828; ENSP00000480328; ENSG00000136098. [P51956-1]
DR   Ensembl; ENST00000611833; ENSP00000484086; ENSG00000136098. [P51956-2]
DR   Ensembl; ENST00000618534; ENSP00000484443; ENSG00000136098. [P51956-1]
DR   GeneID; 4752; -.
DR   KEGG; hsa:4752; -.
DR   UCSC; uc032agd.2; human. [P51956-1]
DR   CTD; 4752; -.
DR   DisGeNET; 4752; -.
DR   GeneCards; NEK3; -.
DR   HGNC; HGNC:7746; NEK3.
DR   HPA; HPA019062; -.
DR   HPA; HPA043230; -.
DR   MIM; 604044; gene.
DR   neXtProt; NX_P51956; -.
DR   OpenTargets; ENSG00000136098; -.
DR   PharmGKB; PA31547; -.
DR   eggNOG; KOG0589; Eukaryota.
DR   eggNOG; ENOG410Y7JF; LUCA.
DR   GeneTree; ENSGT00760000118997; -.
DR   HOGENOM; HOG000261617; -.
DR   HOVERGEN; HBG003063; -.
DR   InParanoid; P51956; -.
DR   KO; K20873; -.
DR   OMA; PEIIMEY; -.
DR   OrthoDB; EOG091G0GU4; -.
DR   PhylomeDB; P51956; -.
DR   TreeFam; TF106472; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SignaLink; P51956; -.
DR   GeneWiki; NEK3; -.
DR   GenomeRNAi; 4752; -.
DR   PRO; PR:P51956; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000136098; -.
DR   CleanEx; HS_NEK3; -.
DR   ExpressionAtlas; P51956; baseline and differential.
DR   Genevisible; P51956; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; NAS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0030010; P:establishment of cell polarity; IEA:Ensembl.
DR   GO; GO:0007067; P:mitotic nuclear division; NAS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0090043; P:regulation of tubulin deacetylation; IEA:Ensembl.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Cell cycle;
KW   Cell division; Cell projection; Complete proteome; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Mitosis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    506       Serine/threonine-protein kinase Nek3.
FT                                /FTId=PRO_0000086423.
FT   DOMAIN        4    257       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      10     18       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1    285       Interaction with VAV2.
FT                                {ECO:0000269|PubMed:15618286}.
FT   ACT_SITE    127    127       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      33     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     161    161       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     479    479       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ     293    309       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12063396}.
FT                                /FTId=VSP_035427.
FT   VARIANT      23     23       H -> L (in dbSNP:rs17482764).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_033906.
FT   VARIANT      60     60       P -> R (in dbSNP:rs55946204).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040908.
FT   VARIANT     122    122       R -> H (in dbSNP:rs56190615).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040909.
FT   VARIANT     170    170       P -> L (in dbSNP:rs56021040).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040910.
FT   VARIANT     259    259       R -> G (in dbSNP:rs34077016).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040911.
FT   VARIANT     305    305       E -> D (in dbSNP:rs55969405).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040912.
FT   VARIANT     461    461       D -> N (in dbSNP:rs34076988).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040913.
FT   VARIANT     477    477       E -> K (in dbSNP:rs34488913).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040914.
FT   CONFLICT     14     14       S -> F (in Ref. 1; BAC15599).
FT                                {ECO:0000305}.
FT   CONFLICT     54     54       L -> S (in Ref. 6; CAA82310).
FT                                {ECO:0000305}.
FT   CONFLICT     77     78       IV -> LY (in Ref. 7; CAA80921).
FT                                {ECO:0000305}.
FT   CONFLICT    187    189       SLG -> PSV (in Ref. 7; CAA80921).
FT                                {ECO:0000305}.
SQ   SEQUENCE   506 AA;  57705 MW;  4437EB4A41A44777 CRC64;
     MDDYMVLRMI GEGSFGRALL VQHESSNQMF AMKEIRLPKS FSNTQNSRKE AVLLAKMKHP
     NIVAFKESFE AEGHLYIVME YCDGGDLMQK IKQQKGKLFP EDMILNWFTQ MCLGVNHIHK
     KRVLHRDIKS KNIFLTQNGK VKLGDFGSAR LLSNPMAFAC TYVGTPYYVP PEIWENLPYN
     NKSDIWSLGC ILYELCTLKH PFQANSWKNL ILKVCQGCIS PLPSHYSYEL QFLVKQMFKR
     NPSHRPSATT LLSRGIVARL VQKCLPPEII MEYGEEVLEE IKNSKHNTPR KKTNPSRIRI
     ALGNEASTVQ EEEQDRKGSH TDLESINENL VESALRRVNR EEKGNKSVHL RKASSPNLHR
     RQWEKNVPNT ALTALENASI LTSSLTAEDD RGGSVIKYSK NTTRKQWLKE TPDTLLNILK
     NADLSLAFQT YTIYRPGSEG FLKGPLSEET EASDSVDGGH DSVILDPERL EPGLDEEDTD
     FEEEDDNPDW VSELKKRAGW QGLCDR
//
